Xiaoling Xie

机构：Lanzhou Jiaotong University, Shantou University, Shantou University Medical College, Chaozhou Central Hospital, Shanxi Science and Technology Department, Taiyuan University of Technology · ORCID：0000-0002-0092-900X

发表论文 80 篇 · 总被引 2550 次 · h-index 26

代表论文

• Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers (2018 · Journal of Medicinal Chemistry · 被引 243)
• Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor (2017 · ACS Medicinal Chemistry Letters · 被引 120)
• A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration (2024 · Cell stem cell · 被引 63)
• Antibacterial poly(butylene succinate-co-terephthalate)/titanium dioxide/copper oxide nanocomposites films for food packaging applications (2022 · Food Packaging and Shelf Life · 被引 42)
• Analysis of public opinion on food safety in Greater China with big data and machine learning (2023 · Current Research in Food Science · 被引 41)
• Enhanced Ocular Delivery of Beva via Ultra‐Small Polymeric Micelles for Noninvasive Anti‐VEGF Therapy (2024 · Advanced Materials · 被引 36)